Nanotechnology for enhanced bioactivity of bioactive phytomolecules

Nutrient Delivery

Volumn , Issue , 2016, Pages 413-456

  Singh, Raghuraj ^a   Kumari, Premlata ^b   Kumar, Satyanshu ^a  

^a ICAR DIRECTORATE OF MEDICINAL AND AROMATIC PLANTS RESEARCH   (India)

^b SARDAR VALLABHBHAI NATIONAL INSTITUTE OF TECHNOLOGY   (India)

Author keywords

bioavailability; nanoglycosomes; nanomedicine; phytochemicals; phytomolecules; phytopharmacology

Indexed keywords

EID: 85062147168     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-804304-2.00011-1     Document Type: Chapter

References (224)

1. A.S. Abreu, E.M. Castanheira, M.J. Queiroz, P.M. Ferreira, L.A. Vale-Silva and E. Pinto (2011) Nanoliposomes for encapsulation and delivery of the potential antitumoral methyl 6-methoxy-3-(4-methoxyphenyl)-1H-indole-2-carboxylate. Nanoscale Res. Lett. 6 482.
2. R. Abu Dahab, F. Odeh, S.I. Ismail, H. Azzam and A. Al Bawab (2013) Preparation, characterization, and antiproliferative activity of thymoquinon-β-cyclodextrin self-assembly nanoparticles. Die. Pharmazie. 68 939-944.
3. W.W. Adams and R.H. Baughman (1916) Retrospective: Richard E. Smalley (1943–2005). Science 310(5756),
4. N.P. Aditya, M. Shim, I. Lee, Y. Lee, M.H. Im and S. Ko (2013) Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity. J. Agric. Food Chem. 61 1878-1883.
5. S. Ahmed, J. Anuntiyo, J.C. Malemud and T.M. Haqqi (2005) Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evid.-Based Compl. Alt. 2 301-308.
6. S. Ajazuddin and S. Saraf (2010) Applications of novel drug delivery system for herbal formulations. Fitoter. 81 680-689.
7. F. Allhoff, P. Lin and D. Moore (2010) What is Nanotechnology and Why Does it Matter? From Science to Ethics. John Wiley & Sons pp. 3–5
8. P. Anand, S.G. Thomas, A.B. Kunnumakkara, C. Sundaram, K.B. Harikumar, B. Sung, S.T. Tharakan, K. Misra, I.K. Priyadarsini, K.N. Rajasekharan and B.B. Aggarwal (2008) Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem. Pharmacol. 76 1590-1611.
9. N. Anton and T.F. Vandamme (2011) Nanoemulsions microemulsions: clarifications of the critical differences. Pharm. Res. 28 978-985.
10. S.S. Bansal, M. Goel, F. Aqil, M.V. Vadhanam and R.C. Gupta (2011) Advanced drug delivery systems of curcumin for cancer chemoprevention. Cancer Prev. Res. (Phila.) 4 1158-1171.
11. X. Bao, Z. Wang, J. Fang and X. Li (2002) Structural features of an immunostimulating and antioxidant acidic polysaccharide from the seeds of Cuscuta chinensis. Planta Medica 68 237-243.
12. A. Bargoni, R. Cavalli, O. Caputo, A. Fundaro, M.R. Gasco and G.P. Zara (1998) Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharm. Res. 15 745-750.
13. A. Barras, A. Mezzetti, A. Richard, S. Lazzaroni, S. Roux, P. Melnyk, et al. (2009) Formulation and characterization of polyphenol-loaded lipid nanocapsules. Int. J. Pharm. 379 270-277.
14. J.A. Baur and D.A. Sinclair (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5 493-506.
15. J.A. Baur, K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, A. Kalra, V.V. Prabhu, J.S. Allard, G. Lopez-Lluch, K. Lewis, P.J. Pistell, S. Poosala, K.G. Becker, O. Boss, D. Gwinn, M. Wang, S. Ramaswamy, K.W. Fishbein, R.G. Spencer, E.G. Lakatta, D. Le Couteur, R.J. Shaw, P. Navas, P. Puigserver, D.K. Ingram, R. de Cabo and D.A. Sinclair (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 337-342.
16. D. Bennet, M. Marimuthu, S. Kim and J. An (2012) Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery. Int. J. Nanomed. 7 3399-3419.
17. G. Binnig and H. Rohrer (1986) Scanning tunneling microscopy. IBM J. Res. Dev. 30 4.
18. B.V. Bonifacio, P.B. daSilva, M. Aparecidodos, S. Ramos, K.M.S. Negri, T.M. Bauab and M. Chorilli (2014) Nanotechnology-based drug delivery systems and herbal medicines: a review. Int. J. Nanomed. 9 1-15.
19. S. Bose and B. Michniak-Kohn (2012) Preparation and characterization of lipid-based nanosystems for topical delivery of quercetin. Eur. J. Pharm. Sci. 48 442-452.
20. M. Brcuning, S. Baucr and A. Gocpferich (2008) Polymers and nanoparticlcs: intelligent tools for intracellular targeting. Eur. J. Pharm. Biopharm. 68(I), 12-128.
21. I. Capek (2004) Degradation of kinetically-stable o/w emulsions. Adv. Colloid Interface Sci. 107 125-155.
22. K.G. Carrasuillo, A.M. Stanley, J.C. Aponte-carro, D.E. Jesus, H.R. Costaritino, C.J. Bosques and K. Griebnow (2001) Non-aqueous encapsulation of excipient-microspheres results in release of native protein. J. Co Tr. Rel. 76 199-208.
23. A. Cassidy, P. Albertazzi and I. Lisc Nielsen (2006) Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc. Nutr. Soc. 65 76-92.
24. R. Cavalli, A. Bargoni, V. Podio, E. Muntoni, G.P. Zara and M.R. Gasco (2003) Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin. J. Pharm. Sci. 92 1085-1094.
25. S. Chakraborty, S. Stalin, N. Das, S.T. Choudhury, S. Ghosh and S. Swarnakar (2012) The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat. Biomaterials 33 2991-3001.
26. N. Chehl, G. Chipitsyna, Q. Gong, C.J. Yeo and H.A. Arafat (2009) Antiinflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) 11(5), 373-381.
27. L. Chen, M.J. Lee, H. Li and C.S. Yang (1997) Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab. Dispos. 25 1045-1050.
28. P. Chen, D.H. Wang, W.Y. Lei and Z.Q. Shen (2006) Effects of scutcllarin on thrombosis and platelet aggregation. J. Kunming Med. Univ. 27 1-5.
29. Y. Chen, X. Lin, H. Park and R. Greever (2009) Study of arternisinin nanocapsules as anticancer drug delivery systems. Nanomed. Nanotechnol. 3 316-322.
30. K.J. Chen, L. Tang, M.A. Garica, H. Wan, H. Lu, W.Y. Lin, et al. (2012) The therapeutic efficacy of camptothecin-encapsulated supermolecular nanoparticle. Biomaterials 33 1162-1169.
31. Z. Cheng, A. Al Zaki, J.Z. Hui, V.R. Muzykantov and A. Tsourkas (2012) Multifunctional: nanoparticles cost versus benefit of adding targeting and imaging capabilities. Science 338(6109), 903-910.
32. G. Chen-yu, Y. Chun-fen, L. Qi-lu, T. Qi, X. Yan-wei, L. Wei-na and Z. Guang-xi (2012) Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int. J. Pharm. 430 292-298.
33. G. Cordell (2002) Natural products in drug discovery—creating a new vision. Phytochem. Rev. 1(3), 261-273.
34. G.M. Cragg, D.G. Newman and K.M. Snader (1997) Natural products in drug discovery and development. J. Nat. Prod. 60 52-60.
35. A.S.C. Cunha Jr., S.L. Fialho, L.B. Carneiro and F. Oréfice (2003) Microemulsões como veículo de drogas para administração ocular tópica [Microemulsion as a vehicle for drugs in topical ocular administration]. Arq. Bras. Oftamol. 66(3), 385-391.
36. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A. Le Breton and V. Preat (2012) PLGA-based nanoparticles: an overview of biomedical applications. J. Control. Release. 161 505-522.
37. S. Das and A. Chaudhury (2011) Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS Pharm. Sci. Tech. 12 62-76.
38. R.C. de Pace, X. Liu, M. Sun, S. Nie, J. Zhang, Q. Cai, W. Gao, X. Pan, Z. Fan and S. Wang (2013) Anticancer activities of (−)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. J. Liposome Res. 23 187-196.
39. P.A.G.M. De Smet (1997) The role of plant-derived drugs and herbal medicines in healthcare. Drugs 54 801-840.
40. A. Dembinski, Z. Warzecha, S.J. Konturek, P. Ceranowicz, M. Oembinski, W.W. Pawlik, et al. (2004) Extract of grapefruit-seed reduces acute pancreatitis induced by ischemiaJreperfusion in rats: possible implication of tissue antioxidants. J. Physiol. Pharmacol. 55 811-815.
41. N. Desai (2012) Challenges in development of nanoparticle-based therapeutics. AAPS J. 14 282-295.
42. Detoni, C.B., Souto, G.D., da Silva, A.L., Pohlmann, A.R., Guterres, S.S., 2012. Photostability and skin penetration of different E-resveratrol-loaded supramolecular structures. Photochem. Photobiol. 88, 913–921.
43. S. Dhawan, R. Kapil and B. Singh (2011) Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. J. Pharm. Pharmacol. 63 342-351.
44. S. Doggui, J.K. Sahni, M. Arseneault, L. Dao and C. Ramassamy (2012) Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line. J. Alzheimers Dis. 30 377-392.
45. Dong, X., Mattingly, C.A., Tseng, M., Cho, M., Adarns, V.R. Mumper, R.J., 2009. Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization. Eur. J. Pharm. Biopharm. 72 (1), 9–17.
46. A. Dube, J.A. Nicolazzo and I. Larson (2010) Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallate. Eur. J. Pharm. Sci. 41 219-225.
47. M.S. EI-samaligy, N.N. Afifi and E.A. Mahmoud (2006) Evaluation of hybrid liposornes encapsulated silymarin regarding physical stability and in vivo performance. Int. J. Pharm. 319 121-129.
48. I. Erlund, E. Meririnne, G. Alfthan and A. Aro (2001) Plasma kinetics and urinary excretion of the f1avanones naringcnin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J. Nutr. 131 235-240.
49. R. Fang, R. Hau, X. Wu, Q. Li, X. Leng and H. Jing (2011) Buvine scrum albumin nanuparticlcs promotes the stability of quercetin in simulated interstinal fluid. J. Agric. Food Chem. 59 6292-6298.
50. Fessi, H., Puisieux, F., Devissaguet, J.Ph., Ammoury, N., Benita, S., 1989. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55, 1–4.
51. N.R. Fransworth and R.W. Morris (1976) Higher plants—the sleeping giant of drug development. Am J. Pharm. Educ. 148 46-52.
52. R.L. Frozza, A. Bernardi, K. Paese, J.B. Hoppe, T. da Silva, A.M. Battastini and C. Salbego (2010) Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. J. Biomed. Nanotechnol. 6 694-703.
53. K. Fukuda, Y. Hibiya and M. Mutoh (1999) Inhibition of activation protein 1 activity by berberine in human hepatoma cells. Planta. Med. 65 381-383.
54. K. Fukuda, Y. Hibiya, M. Mutuh, M. Kushiji, S. Akau and H. Fujiwara (1999) Inhibitiun by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J. Ethnopharmacol. 66 227-233.
55. G. Gall, M.S. DuPont, F.A. Mellon, A.L. Davis, G.J. Collins, M.E. Verhoeyen and I.J. Colquhoun (2003) Characterization and content of flavonoid glycosides in genetically modified tomato (Lycopersicon esculentum) fruits. J. Agric. Food Chem. 51(9), 2438-2442.
56. R. Gao, B.H. Zhu, S.B. Tang, J.F. Wang and J. Ren (2008) Scutellarein inhibits hypoxia- and moderately-high glucose-induced proliferation and VEGF expression in human retinal endothelial cells. Acta. Pharmacal. Sin. 29 707-712.
57. Y. Gao, C. Wang, M. Sun, X. Wang, A. Yu, A. Li and G. Zhai (2012) In vivo evaluation of curcumin-loaded nanosuspensions by oral administration. J. Biomed. Nanotechnol. 8 659-668.
58. Q.H. Ge, Z. Zou, X.J. Zhi, L.L. Ma and X.H. Chen (2003) Pharmacokinetics and absolute bioavailability of breviscapine in beagle dogs. Chin. J. Pharm. 34 618-620.
59. A. Ghosh, B. Das, A. Roy, B. Mandal and G. Chandra (2008) Antibacterial activity of some medicinal plant extracts. J. Nat. Med. 62 259-262.
60. D. Ghosh, S. Ghosh, S. Sarkar, A. Ghosh, N. Das, K. Das Saha and A.K. Mandal (2010) Quercetin in vesicular delivery systems: evaluation in combating arsenic-induced acute liver toxicity associated gene expression in rat model. Chem. Biol. Interact. 186 61-71.
61. V. Ghosh, S. Saranya, A. Mukherjee and N. Chandrasekaran (2013) Antibacterial microemulsion prevents sepsis and triggers healing of wound in wistar rats. Colloid. Surf. B. 105 152-157.
62. M. Gleave, N. Bruchovsky, S.L. Goldenberg and P. Rennie (1998) Intermittent androgen suppression fur prostate cancer: rationale and clinical experience. Eur. Urol. 34 37-41.
63. E.H. Gokce, E. Korkmaz, E. Dellera, G. Sandri, M.C. Bonferoni and O. Ozer (2012) Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int. J. Nanomed. 7 1841-1850.
64. J. Gong, M. Chen, Y. Zheng, S. Wang and Y. Wang (2012) Polymeric micelles drug delivery system in oncology. J. Control. Release. 159 312-323.
65. T. Govender, L. Stolnik, M.C. Garnett, L. Illum and S.S. Davis (1999) PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of water-soluble drug. J. Co Tr. Rel. 57 171-185.
66. L. Guo, Y. Peng, J. Yao, L. Sui, A. Gu and J. Wang (2010) Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice. Cancer Biother. Radio. 25 471-477.
67. R.N. Gursoy and S. Benita (2004) Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58 173-182.
68. J. He, J.F. Feng, L.L. Zhang, W.G. Lu and S.X. Hou (2005) Freeze- drying of silymarin-loaded solid nanoparticles. China J. Chinese Mat. Med. 30 110-112.
69. S. Hirai, Y.I. Kirn, T. Goto, M.S. Kang, M. Yoshimura and Obata FA. (2007) Inhibitory effect of naringenin chalcone on inflammatory changes in the interaction between adipocytes and macrophages. Life Sci. 81 1272-1277.
70. P.C. Hollman, M. vd Gaag, M.J. Mengelers, J.M. van Trijp, J.H. de Vries and M.B. Katan (1996) Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radical Bio. Med. 21 703-707.
71. C. Hsin-I and Y. Ming-Kung (2012) Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int. J. Nanomed. 7 49-60.
72. L.D. Hu, Q. Xing, J. Meng and C. Shang (2010) Preparation and enhanced bioavailability of cryptotanshinone-loaded solid lipid nanoparticles. AAPS Pharm. Sci. Tech. 11(2), 582-587.
73. B. Hu, Y. Ting, X. Yang, W. Tang, X. Zeng and Q. Huang (2012) Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. Chem. Commun. (Camb.) 48 2421-2423.
74. B. Hu, Y. Ting, X. Zeng and Q. Huang (2013) Bioactive peptides/chitosan nanoparticles enhance cellular antioxidant activity of (−)-epigallocatechin-3- gallate. J. Agric. Food Chem. 61 875-881.
75. M.L. Immordino, F. Dosio and L. Cattel (2006) Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomed. 1(3), 297-315.
76. M.A. Iqbal, S. Md, J.K. Sahni, S. Baboota, S. Dang and J. Ali (2012) Nanostructured lipid carriers system: recent advances in drug delivery. J. Drug Target. 20 813-830.
77. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher and H.H. Fong (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 218-220.
78. V. Jenning, A. Lippacher and S.H. Gohla (2002) Medium scale production of solid lipid nanoparticles (SLN) by high-pressure homogenization. J. Microencapsul. 19 1-10.
79. Kahn, J., 2006. ‘Nanotechnology. National Geographic 2006 (June): 98–119.
80. V. Kakkar, S. Singh, D. Singla and I.P. Kaur (2011) Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol. Nutr. Food Res. 55 495-503.
81. D.G. Kang, H. Oh, E.J. Sohn, T.Y. Hur, K.C. Lee, K.J. Kim, T.Y. Kim and H.S. Lee (2004) Lithosperrnic acid B isolated from Salvia miltiorrhiza ameliorates ischemia/reperfusion-induced renal injury in rats. Life Sci. 75 1801-1816.
82. S. Kanno, A. Tornizawa, T. Hiura, Y. Osanai, A. Shouji, M. Ujibe, T. Ohtake, K. Kirnura and M. Ishikawa (2005) Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice. Biol. Pharm. Bull. 28(3), 527-533.
83. K. Kataoka, H. Togawa, A. Harada, K. Yasugi, T. Matsumoto and S. Katayose (1996) Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline. Macromolecules 29 8556-8557.
84. R. Kaur, A. Hasan, N. Iqbal, S. Alam, M.K. Saini and S.K. Raza (2014) Synthesis and susface engineering of magnetic nanoparticles for environmental cleanup and pesticide residue analysis: a review. J. Sep. Sci. 37 1805-1825.
85. U. Kedar, P. Phutane, S. Shidhaye and V. Kadam (2010) Advances in polymeric micelles for drug delivery and tumor targeting. Nanomed. Nanotechnol. 6 714-729.
86. N.M. Khalil, T.C. do Nascimento, D.M. Casa, L.F. Dalmolin, A.C. de Mattos, I. Hoss, M.A. Romano and R.M. Mainardes (2013) Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. Colloid. Surf. B 101 353-360.
87. S.A. Kim, Y. Kwon, J.H. Kim, M.T. Muller and I.K. Chung (1998) Induction of topoisornerase II-rnediated DNA cleavage by a protoberberine alkaloid, berberrubine. Biochemistry 37 16316-16324.
88. T.H. Kim, H.H. Jiang, Y.S. Youn, C.W. Park, K.K. Tak, S. Lee, H. Kim, S. Jon, X. Chen and K.C. Lee (2011) Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int. J. Pharm. 403 285-291.
89. H.W. Kroto, J.R. Heath, S.C. O’Brien, R.F. Curl and R.E. Smalley (1985) C60: Buckminsterfullerene. Nature 318(6042), 162.
90. M.H.V. Kumar (2002) Effect of different extracts of Centella asiatica on cognition and markers of oxidative stress in rats. J. Ethnopharmacol. 79 253-260.
91. A. Kumari, S.K. Yadav, Y.B. Pakade, B. Singh and S.C. Yadav (2010) Development of biodegradable nanoparticles for delivery of quercetin. Colloid. Surf. B 80 184-192.
92. A. Kumari, S.K. Yadav and S.C. Yadav (2010) Biodegradable polymeric nanoparticles-based drug delivery systems. Colloid. Surf. B 75 1-18.
93. A. Kumari, V. Kumar and S.K. Yadav (2012) Plant extract synthesized PLA nanoparticles for controlled and sustained release of quercetin: a green approach. PLoS One 7 e41230
94. R. Kunii, H. Onishi and Y. Machida (2007) Preparation and antiturnor characteristic of PLA/(PEG-PPG-PEG) nanoparticle loaded with camptothecin. Eur. J. Pharm. Biopharm. 67 9-17.
95. G.S. Kwon, M. Naito, M. Yokoyama, T. Okano, Y. Sakurai and K. Kataoka (1995) Physical entrapment of adriamycin in AB block copolymer micelles. Pharm. Res. 12 192-195.
96. C.A. Lamartinicrc, W.B. Murill and P.A. Manzolillo (1998) Genistcin alters the ontogeny of mammary cancer development and protects against mammary cancer in rat. Pro. Sac. Exp. Biol. Med. 217 358-364.
97. R. Langer (1990) New methods of drug delivery. Science 249 1527-1533.
98. D.D. Lasic, F.J. Martin, A. Gabizon, S.K. Huang and D. Papahadjopoulos (1991) Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta. 1070 187-192.
99. M.J. Lee, P. Maliakal, L. Chen, X. Meng, F.Y. Bondoc, S. Prabhu, G. Lambert, S. Mohr and C.S. Yang (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarter. 11 1025-1032.
100. M.H. Lee, S. Yoon and J.O. Moon (2004) The flavonoid naringenin inhibits dimethylnitrosamine-induced liver damage in rats. Biol. Pharm. Bull. 27 72-78.
101. C.W. Lee, F.L. Yen, H.W. Huang, T.H. Wu, H.H. Ko, W.S. Tzeng and C.C. Lin (2012) Resveratrol nanoparticle system improves dissolution properties and enhances the hepatoprotective effect of resveratrol through antioxidant and antiinflammatory pathways. J. Agric. Food Chem. 60 4662-4671.
102. A.M. Li (2009) Research on intervention effect of breviscapme injection on rats with pulmonary fibrosis. Proc. Clin. Med. 18 511-514.
103. H. Li, X. Zhao, Y. Ma, G. Zhai, L. Li and H. Lou (2009) Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Release 133 238-244.
104. L. Li, J. Zeng, Y. Gao and D. He (2010) Targeting silibinin in the antiproliferative pathway. Expert Opin. Inv. Drug. 19 243-255.
105. C. Li, X. Zhang, X. Huang, X. Wang, G. Liao and Z. Chen (2013) Preparation and characterization of flexible nanoliposomes loaded with daptomycin, a novel antibiotic, for topical skin therapy. Int. J. Nanomed. 8 1285-1292.
106. S.B. Lim, A. Banerjee and H. Onyuksel (2012) Improvement of drug safety by the use of lipid-based nanocarriers. J. Control. Release 163 34-45.
107. A. Limaa, C. Pizzolb, F. Monteirob, T. Creczynski-Pasab, G. Andradec, A. Ribeiroc and J. Perussia (2013) Hypericin encapsulated in solid lipid nanoparticles: phototoxicity and photodynamic efficiency. J. Photochem. Photobiol. B 125(1), 146-154.
108. J.G. Lin, J.G. Chung and L.T. Wu (1999) Effects of berberine on arylarnine Nacetyl-transferase activity in human colon turnor cells. Am. J. Chin. Med. 27 265-275.
109. L.F. Liu (1989) DNA topoisomerasc poisons as antitumor drugs. Annu. Rev. Biochem. 8351-8375.
110. J.H. Liu, B. Jiang, Y.M. Bao and L.J. An (2003) Effect of Cuscuta chinensis glycoside on the neuronal differentiation of rat pheochromocytoma PC12 cells. Int. J. Dev. Neurosci. 21 277-281.
111. Y.M. Liu, A.H. Lin, H. Chen and F.D. Zeng (2003) Study on pharmacokinetics of scutellarin in rabbits. Acta. Pharm. Sinica. 38 775-778.
112. J.R. Liu, G.F. Chen, H.N. Shih and P.C. Kuo (2008) Enhanced antioxidant bioactivity of Salvia miltiorrhira (Danshen) products prepared using nanotechnology. Phytomedicine 15 23-30.
113. X. Lu, C. Ji, H. Xu, X. Li, H. Ding, M. Ye and X. Guo (2009) Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress. Int. J. Pharm. 375 89-96.
114. A. Mahapatro and D.K. Singh (2011) Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J. Nanobiotechnol. 9 55.
115. C. Manach, A. Scalbert and C. Morand (2004) Am. J. Clin. Nutr. 79 727-747.
116. M.A. Mansour, M.N. Nagi, A.S. El-Khatib and A.M. Al-Bekairi (2002) Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: a possible mechanism of action. Cell Biochem. Funct. 20(2), 143-151.
117. S. Martins, S. Costa-Lima, T. Carneiro, A. Cordeiro-da-Silva, E.B. Souto and D.C. Ferreira (2012) Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway. Int. J. Pharm. 430(1-2), 216-227.
118. M. Mathur and G. Vyas (2013) Role of nanoparticles of smart herbal drug—an overview. Indian J. Nat. Prod. Res. 44(4), 329-338.
119. D.J. McClements, E.A. Decker and J. Weiss (2007) Emulsion-based delivery systems for lipophilic bioactive components. J. Food Sci. 72 R109-R124.
120. B.L. McNiff (1977) Clinical use of 10% soybean oil emulsion. Am. J. Hosp. Pharm. 34 1080-1086.
121. W. Mehnert and K. Mader (2001) Solid lipid nanoparticles: production, characterization, and applications. Adv. Drug Deliv. Rev. 47 165-196.
122. Z. Mei, H. Chen, T. Wneg, Y. Yang and X. Yang (2003) Solid lipid nanoparticles and rnicremulsion for tropical delivery of triptolide. Eur. J. Pharm. Biopharm. 56(2), 189-196.
123. Melis C., Ali D.S., Seyda B., 2014. Liposomes as potential drug carrier systems for drug delivery. In : D.S. Ali (Ed.), Application of Nanotechnology in Drug Delivery. InTech., pp. 1–50.
124. C. Mohanty and S.K. Sahoo (2010) The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 31 6597-6611.
125. D. Momekova, S. Rangelov, S. Yanev, E. Nikolova, S. Konstantinov, B. Romberg, G. Storm and N. Lambov (2007) Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units. Eur. J. Pharm. Sci. 32 308-317.
126. M.R. Mozafari (2010) Nanoliposomes: preparation and analysis. Methods Mol. Biol. 605 29-50.
127. M.R. Mozafari, A. Pardakhty, S. Azarmi, J.A. Jazayeri, A. Nokhodchi and A. Omri (2009) Role of nanocarrier systems in cancer nanotherapy. J. Liposome Res. 19 310-321.
128. Mross, K., Niemann, B., Massing, U., Drevs, J., Unger, C., Bhamra, R., Swenson C.E., 2004. Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study. Cancer Chemother. Pharmacol. 54 (6), 514–524.
129. R.H. Muller, S. Maassen, H. Weyhers and W. Mehnert (1996) Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J. Drug Target 4 161-170.
130. R.H. Muller, K. Mader and S. Gohla (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur. J. Pharm. Biopharm. 50 161-177.
131. S. Mun, E.A. Decker and D.J. McClements (2005) Influence of droplet characteristics on the formation of oil-in water emulsions stabilized by surfactant-chitosan layers. Langmuir 21 6228-6234.
132. K. Murota and J. Terao (2003) Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys. 417 12-17.
133. K.L. Nair, A.K. Thulasidasan, G. Deepa, R.J. Anto and G.S. Kumar (2012) Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier. Int. J. Pharm. 425 44-52.
134. D. Newman, G. Cragg and K. Snader (2003) Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 66(7), 1022-1037.
135. J.M. Nirmala, A. Samundcewani and D.P. Sankar (2011) Natural plant resources in anticancer therapy: a review. Res. Plant Biol. 1 1-14.
136. M. Nisa, S. Akbar, M. Tariq and Z. Hussain (1986) Effect of Cuscuta chinensis water extract on 7, 12-dimethylbcnz a anthracene-induced skin papillomas and carcinomas in mice. J. Ethnophamacol. 18 21-31.
137. F. Odeh, S.I. Ismail, R. Abu-Dahab, I.S. Mahmoud and A. Al Bawab (2012) Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer. Drug Deliv. 19(18), 371-377.
138. C. Oerlemans, W. Bult, M. Bos, G. Storm, J.F. Nijsen and W.E. Hennink (2010) Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm. Res. 27 2569-2589.
139. K.M. Oksman-Caldentery and D. Inze (2004) Plant-cell factories in the post-genomic era: new ways to produce designer secondary metabolites. Trends Plant Sci. 9 433-440.
140. A.G. Oliveira and M.V. Scarpa (2001) Microemulsões I: fundamentos teóricos da formação do sistema microemulsionado [Microemulsion I: theoreti-cal training of the microemulsion system]. Infarma. 13(9–10), 73-79.
141. A.G. Oliveira, M.V. Scarpa and L.F.R. Cera (2002) Microemulsões II: aplicações de liberação de fármacos [Microemulsions II: applications for drug delivery]. Infarma. 14(7–8), 76-80.
142. F. Orallo (2006) Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr. Med. Chem. 13 87-98.
143. G. Ott, M. Singh, J. Kazzaz, M. Briones, E. Soenawan and M. Ugozzoli (2002) A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines. J. Control. Rel. 79 1-5.
144. G. Padamanaban, A.V. Nagaraj and P.N. Rangarajan (2012) Artirnisinin-based combination with curcumin adds a new dimension to malaria therapy. Curr. Sci. 102 704-712.
145. J. Pardeike, A. Hommoss and R.H. Müller (2009) Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 366(1-2), 170-184.
146. J.W. Park (2002) Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res. 4(3), 95-99.
147. Q. Peng, G. Tao, Z. Jiao, L. Jie, Z. Dong and Z. Zhirong (2008) Enhanced the oral bioavailability of savianolic acid B by phospholipid complex loaded nanoparticles. Die Pharmazie (Int. J. Pharmaceutical Sci.) 63 661-666.
148. L.B. Peppas and J.O. Blanchette (2004) Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56 1649-1659.
149. S. Pinnamaneni, N.G. Das and S.K. Das (2003) Comparison of oil-in-water emulsions manufactured by microfluidization and homogenization. Pharmazie 58 554-558.
150. S.K. Prasad (2008) Modern Concepts in Nanotechnology. Discovery Publishing House 31–32
151. T. Prasad and K. Rajendra kumar (2004) Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-JR, X-ray diffraction and SEM analysis. J. Pharm. Biomed. Anal. 34 333-339.
152. Press release: the 1986 Nobel Prize in Physics. Nobelprize.org. 15 October 1986.
153. S. Proniuk, B.M. Liederer and J. Blanchard (2002) Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention. J. Pharm. Sci. 91 111-116.
154. C. Puglia and F. Bonina (2012) Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin. Drug Deliv. 9 429-441.
155. A. Puri, K. Loomis, B. Smith, J.H. Lee, A. Yavlovich, E. Heldman and R. Blumenthal (2009) Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit. Rev. Ther. Drug Carrier Syst. 26 523-580.
156. S. Rajamanickam, B. Velmurugan, M. Kaur, R.P. Singh and R. Agarwal (2010) Chemoprevention of intestinal tumorignesis in APCmin/+mice by silibinin. Cancer Res. 70 2368-2378.
157. R. Rajendran, R. Radhai, T.M. Kotresh and E. Csiszar (2013) Development of antimicrobial cotton fabrics using herb-loaded nanoparticles. Carbohydr. Polym. 91(2), 613-617.
158. J. Ravindran, H.B. Nair, B. Sung, S. Prasad, R.R. Tekmal and B.B. Aggarwal (2010) Thymoquinone poly(lactide-co-glycolide) nanoparticles exhibit enhanced antiproliferative, aAntiinflammatory, and chemosensitization potential. Biochem. Pharmacol. 79 1640-1647.
159. P. Reichardt, O.S. Nielsen, S. Bauer, J.T. Hartmann, P. Schoffski, T.B. Christensen, et al. (2007) Exatecan in pretreated adult patients with advanced soft tissue sarcoma: result of a phase-II. A study of EORTC soft tissue and bone sarcoma group. Euro. J. Cancer 43 1017-1022.
160. Rodgers, P., 2006. Nanoelectronics: single file. Nat. Nanotechnol.
161. A.M. Roy, M.S. Baliga, C.A. Elrnets and S.K. Kntiyar (2005) Grapeseed proanthocyanidins induce apoplosis through p53, Bax, and caspasc-S pathways. Neoplasia 7 24-36.
162. A. Rusin, Z. Krawezyk, G. Grynkiewicz, A. Gogler, J. Zawisza- Puchalka and W. Szeja (2010) Synthetic derivatives of genistein, their properties and possible application. Acta Biochim. Pol. 57 23-34.
163. D. Sakarkar and V. Deshmukh (2011) Ethnopharmacological review of traditional medicinal plants for anticancer activity. Int. J. Pharma. Tech. Res. 3 298-308.
164. R.A. Sanad, N.S. Abdelmalak, T.S. Elbayoomy and A.A. Badawi (2010) Formulation of a novel oxybenzoneloaded nanostructured lipid carriers (NLCs). AAPS Pharm. Sci. Tech. 11 1684-1694.
165. V. Sanna, A.M. Roggio, S. Siliani, M. Piccinini, S. Marceddu, A. Mariani and M. Sechi (2012) Development of novel cationic chitosan-and anionic alginate-coated poly (D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol. Int. J. Nanomed. 7 5501-5516.
166. F.K. Santos, M.H. Oyafuso, C.P. Kiill, M.P.D. Gremião and M. Chorilli (2013) Nanotechnology-based drug delivery systems for treatment of hyperproliferative skin diseases—a review. Curr. Nanosci. 9(1), 159-167.
167. Sathyavathi, G.V., Gupra, A.K., Tandon, N., 1987. Medicinal Plants of India. Vol. 2. New Delhi (India). Indian Council of Medical Research, pp. 230–239.
168. J. Shaikh, D.D. Ankola, V. Beniwal, D. Singh and M.N. Kumar (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci. 37 223-230.
169. J. Shaji and V. Patole (2008) Protein and Peptide drug delivery: oral approaches. Indian J. Pharm. Sci. 70(3), 269-277.
170. Shao, J., Li, X., Lu, X., Jiang, C., Hu, Y., Li, Q., Fu, Z., 2009. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloid. Surf. B. 72, 40–47.
171. S. Shinji, T. Yasukazu, W. Hatsue, K. Kazuo, I. Machiko and M. Naoki (2011) Analysis of brain cell activation by nanosized particles of Ginkgo biloba extract. Intern. J. Plant Physiol. Biochem. 3(3), 28-33.
172. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran and P.S. Srinivas (1998) Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta. Med. 64 353-356.
173. Y.Z. Shu (1998) Recent natural products-based drug development: a pharmaceutical industry perspective. J. Nat. Prod. 61 1053-1071.
174. Si, Hua- Yan, Li, Dong-Peng, Wang, Tian-Ming, Zhang, Hao-Li, Ren, Fang- Yuan, Xu, Zhu-Guo and Zhao, Yu- Yuan, J., 2010. Improving the antitumor effect of genistein with a biocompatible superparamagnetic drug delivery system. J. Nanosci. Nanotechnol. 10 (4), pp. 2325–2331.
175. I.A. Siddiqui, V.M. Adhami, D.J. Bharali, B.B. Hafeez, M. Asim, S.I. Khwaja, et al. (2009) Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res. 69 1712-1716.
176. I.A. Siddiqui, D.M. Adhami, M. Ahmad and H. Ahmedmukhtar (2010) Nanochemo prevention: sustained release of bioactive food components for cancer prevention. Nutr. Cancer. 62 883-993.
177. B. Singh, S. Bandopadhyay, R. Kapil, R. Singh and O. Katare (2009) Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit. Rev. Ther. Drug Carrier Syst. 26 427-521.
178. A.K. Singla, A. Garg and D. Aggarwal (2002) Paclitaxel and its formulation. lnt. J. Pharm. 235 179-192.
179. A.C. Sintov and L. Shapiro (2004) New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. J. Control. Rel. 95(2), 173-183.
180. X. Song, Y. Zhao, S. Hou, F. Xu, R. Zhao, J. He and Q. Chen (2008) Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. Eur. J. Pharm. Biopharm. 69 445-453.
181. E.B. Souto, P. Severino, M.H.A. Santana and S.C. Pinho (2011) Nanopartículas de lipídios sólidos: métodos clássicos de produção laboratorial [Solid lipid nanoparticles: classical methods of laboratory production]. Quim. Nova. 34(10), 1762-1769.
182. C.M. Spencer and D. Faulds (1994) Paclitaxel—a review of its pharmacodynamic and pharrnacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 48 794-847.
183. K. Srinivas, J.W. King, L.R. Howard and J.K. Monrad (2010) Solubility and solution thermodynamic properties of quercetin and quercetin dihydrate in subcritical water. J. Food Eng. 100 208-218.
184. T. Stark, S. Barcuthcr and T. Hofmann (2005) Sensory-guided decomposition of roasted cocoa nibs (Theobroma cacao) and structure determination of taste-active polyphcuols. J. Agric. Food Chem. 53 5407-5412.
185. T. Tadano and K. Kisara (1997) Alzheimer’s disease—efficacy of Ginkgo biloba extract. Japan Med. J. 16 116-120.
186. T. Tadros, P. Izquierdo, J. Esquena and C. Solans (2004) Formation and stability of nano-emulsions. Adv. Colloid. Interf. Sci. 108-109. 303–318
187. B.J. Tan, Y. Liu, K.L. Chang, B.K. Lim and G.N. Chiu (2012) Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer. Int. J. Nanomed. 7 651-661.
188. J. Tang, N. Xu, H. Ji, H. Liu, Z. Wang and L. Wu (2011) Edragit nanoparticles containing genistein: formulation, development and bioavailability assessment. Int. J. Nanomed. 6 2429-2435.
189. S. Tang, D. Gao, T. Zhao, J. Zhou and X. Zhao (2013) An evaluation of the antitumor efficacy of oleanolic acid-loaded PEGylated liposomes. Nanotechnology 24 235102.
190. V. Teeranachaideekul, R.H. Muller and V.B. Junyaprasert (2007) Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-effects of formulation parameters on physicochemical stability. Int. J. Pharm. 340 198-206.
191. E. Terreno, D.D. Castelli, C. Cabellab, W. Dastru, A. Saninoa, J. Stancanellob, et al. (2008) Chem. Biodivers. 5 1901-1902.
192. R. Thapa, G. Khan, K. Parajuli-Baral and P. Thapa (2013) Herbal medicine incorporated nanoparticles: advancements in herbal treatment. Asian J. Pharma. Clin. Res. 3(24), 7-14.
193. V.P. Torchilin (2001) Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Rel. 73 137-172.
194. V.P. Torchilin (2007) Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 24 1-16.
195. Y.M. Tsai, C.F. Chien, L.C. Lin and T.H. Tsai (2011) Curcumin, its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int. J. Pharm. 416 331-338.
196. K. Umehara, K. Nemoto, T. Ohkubo, T. Miyase, M. Degaw and H. Noguchi (2004) Isolation of a new 15-membered macrocyclic glycolipid lactone, Cuscutic Resinoside a from the seeds of Cuscuta chinensis: a stimulator of breast cancer cell proliferation. Planta. Med. 70 299-304.
197. M. Uner (2006) Preparation characterization physico-chemical properties of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Pharmazie 61 375-386.
198. T. Usui (2006) Pharmaceutical prospects of phytoestrogens. Endocr. J. 53 7-20.
199. B.E. Van Wyk (1997) Medicinal Plants of South Africa. Pretoria: Briza Publications 78–79
200. R. Verpoorte (2000) Pharmacognosy in the new millenium: leadfinding and biotechnology. J. Pharm. Pharmacol. 52 253-262.
201. H. Wang, M.N. Nair, G. Strashurg GnM, A.M. Booren and J.I. Gray (1999) Antioxidant polyphenols from tart cherries (Prunus cerasus). J. Agric. Food Chem. 47 840-845.
202. B. Wang, L. Ma, X. Tao and P.E. Lipsky (2004) Triptolide an active component of Chinese herbal remedy Tripterygium wiljordii Hook. f., inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Arthritis Rheum. 50 2995-3003.
203. G. Wang, J.J. Wang, G.Y. Yang, S.M. Du, N. Zeng, D.S. Li and F. Ye (2012) Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death. Int. J. Nanomed. 7 271-280.
204. S. Wang, R. Su, S. Nie, M. Sun, J. Zhang, D. Wu and N. Moustaid-Moussa (2014) Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J. Nutr. Biochem. 25(4), 363-376.
205. S. Wang, R. Su, S. Nie, M. Sun, J. Zhang, D. Wu and N. Moustaid-Moussa (2014) Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J. Nutr. Biochem. 25(4), 363-376.
206. M. Werle and H. Takeuchi (2009) Chitosan-aprotinin coated liposomes for oral peptide delivery: development, characterization, and in vivo evaluation. Int. J. Pharm. 370 26-32.
207. M. Werle, H. Takeuchi and A. Bernkop-Schnurch (2009) Modified chitosans for oral drug delivery. J. Pharm. Sci. 98 1643-1656.
208. B. Williams, C.M. Watanabe, P.G. Schultz, G. Rimbach and T. Kruckcr (2004) Age-related effects of Ginkgo biloba extract on synoptic plasticity and excitability. Neurobiol. Aging. 25 955-962.
209. J.S. Woo, T.S. Kim, J.H. Park and S.C. Chi (2007) Formulation and biopharmaeeutical evaluation of silymarin using SMEDDS. Arch. Pharm. Res. 30(1), 82-89.
210. M.C. Woodle and D.D. Lasic (1992) Sterically stabilized liposomes. Biochim. Biophys. Acta. 1113 171-199.
211. W. Wu, Y. Wang and L. Que (2006) Enhanced bioavailability of silyrnarin by self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharm. 63 288-294.
212. Y.L. Xiao and B. Li (2002) Chine. Trad. Herb Drugs 33 385-388.
213. X. Xie, Q. Tao, Y. Zou, F. Zhang, M. Guo, Y. Wang, H. Wang, Q. Zhou and S. Yu (2011) PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J. Agric. Food Chem. 59 9280-9289.
214. F. Xiong, H. Wang, Y.J. Chen, K.K. Geng, N. Gu and J. Zhu (2011) Characterization. bio-distribuuon and targeting evaluation of breviscapine lipid emulsions following intervenous injection in mice. Drug Deliv. 18 159-165.
215. F. Xiong, C. Xiong, J. Yao, X. Chen and N. Gu (2011) Preparation, characterization, and evaluation of breviscapine lipid emulsions coated with monooleate- PEG-COOH. Int. J. Pharm. 421 275-282.
216. M.M. Yallapu, B.K. Gupta, M. Jaggi and S.C. Chauhan (2010) Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J. Colloid Interf. Sci. 351 19-29.
217. F.L. Yen, T.H. Wu, L. Lin, T.M. Cham and C.C. Lin (2008) Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats. Food Chem. Toxicol. 46 1771-1777.
218. M. Yokoyama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka, et al. (1990) Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res. 50 1693-1700.
219. M. Yokoyama, T. Okano, Y. Sakurai, S. Suwa and K. Kataoka (1996) Introduction of cisplatin into polymeric micelles. J. Control. Rel. 39 351-356.
220. J.O. You, Y.C. Liu and C.A. Peng (2006) Efficient gene transfection using chitosan-alginate core-shell nanoparticles. Int. J. Nanomed. 1 173-180.
221. L. Zhang, F.X. Gu, J.M. Chan, A.Z. Wang, R.S. Langer and O.C. Farokhzad (2008) Nanoparticles: in medicine therapeutic applications and developments. Clin. Pharmacol. Ther. 83 761-769.
222. Zheng, H.Z., Dong, Z.H. She, J., 1998. Modern Study of Traditional Chinese Medicine, first ed. Beijing Xue Yuan Press, People’s Republic of China, Beijing, pp. 4110–4120.
223. L. Zhou, M. Chow and Z. Zuo (2006) Improved quality control method for Danshen products—consideration of both hydrophilic and lipophilic active components. J. Pharm. Biomed. Anal. 41 744-750.
224. O. Ziv, R. Avtalion and S. Margel (2008) Immunogenicity of bioactive magnetic nanoparticles: natural and acquired antibodies. J. of Biomed. Mater. Res. A. 85(4), 1011-1021.